Compounds > xanthinol niacinate
Page last updated: 2024-08-21

xanthinol niacinate and Cerebral Arteriosclerosis

xanthinol niacinate has been researched along with Cerebral Arteriosclerosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19907 (87.50)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KESSENS, L1
LAWRENCE, RM; LEICHMAN, NS1
Absava, GI; Erokhina, LG; Iuzhakov, SD; Lebedeva, NV; Mashkovskiĭ, MD1
Mints, AIa1
Ciarimboli, M; Di Grezia, F; Lingetti, E; Lingetti, M; Policicchio, D; Policicchio, F1
Eninia, GI; Lazareva, AIu; Smeltere, ES1
Sanik, AV; Vesel'skiĭ, ISh1
Dorogiĭ, AN; Ishchenko, MM1

Other Studies

8 other study(ies) available for xanthinol niacinate and Cerebral Arteriosclerosis

ArticleYear
[On the treatment of cerebral sclerosis with complamine].
    Die Medizinische Welt, 1960, Nov-19, Volume: 47

    Topics: Intracranial Arteriosclerosis; Niacin; Nicotinic Acids; Theophylline; Tuberous Sclerosis; Xanthinol Niacinate

1960
COMPARISON OF THE EFFECTS OF HEPARIN SODIUM, XANTHINOL NIACINATE (COMPLAMIN) AND 2-DIMETHYL-AMINOETHANOL (DEANER) IN INSTITUTIONALIZED GERIATRIC GROUPS.
    Journal of the American Geriatrics Society, 1965, Volume: 13

    Topics: Antidepressive Agents; Behavior; Biomedical Research; Cerebrovascular Disorders; Deanol; Depression; Depressive Disorder; Drug Therapy; Geriatrics; Heparin; Intracranial Arteriosclerosis; Memory; Niacin; Nursing; Psychological Tests; Theophylline; Toxicology; Xanthinol Niacinate

1965
[Pharmacological properties and clinical use of xanthinol nicotinate].
    Klinicheskaia meditsina, 1984, Volume: 62, Issue:11

    Topics: Animals; Arteriosclerosis; Cats; Diabetic Angiopathies; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Hemodynamics; Humans; Intracranial Arteriosclerosis; Mice; Peripheral Nervous System Diseases; Rats; Raynaud Disease; Theophylline; Xanthinol Niacinate

1984
[Clinical manifestations and treatment of early cerebral atherosclerosis].
    Klinicheskaia meditsina, 1981, Volume: 59, Issue:9

    Topics: Adult; Cerebrovascular Circulation; Follow-Up Studies; Humans; Intracranial Arteriosclerosis; Middle Aged; Plethysmography, Impedance; Time Factors; Xanthinol Niacinate

1981
[Metabolic therapy of atherosclerosis].
    La Clinica terapeutica, 1979, Oct-31, Volume: 91, Issue:2

    Topics: Aged; Arteriosclerosis; Arteriosclerosis Obliterans; Choline; Cytidine Diphosphate Choline; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Male; Theophylline; Xanthinol Niacinate

1979
[Comparative evaluation of complamin action on cerebral vessels].
    Klinicheskaia meditsina, 1975, Volume: 53, Issue:8

    Topics: Cerebral Arteries; Cerebrovascular Circulation; Humans; Intracranial Arteriosclerosis; Theophylline; Vasodilator Agents; Xanthinol Niacinate

1975
[The correction of microcirculatory disorders in patients with circulatory encephalopathy].
    Vrachebnoe delo, 1991, Issue:7

    Topics: Adult; Conjunctiva; Female; Humans; Intracranial Arteriosclerosis; Male; Microcirculation; Middle Aged; Nicergoline; Vasodilator Agents; Vinca Alkaloids; Xanthinol Niacinate

1991
[Effect of complamin on the systemic and cerebral hemodynamics of atherosclerosis patients with chronic cerebral vascular disorders].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1985, Volume: 85, Issue:1

    Topics: Adult; Aged; Blood Circulation Time; Blood Pressure; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Theophylline; Vascular Resistance; Xanthinol Niacinate

1985